DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q May 8, 2025 10-Q
ARS Apr 30, 2025 ARS
DEFA14A Apr 30, 2025 DEFA14A
DEF 14A Apr 30, 2025 DEF 14A
PRE 14A Apr 17, 2025 PRE 14A
S-8 Mar 19, 2025 S-8
10-K Mar 19, 2025 10-K
SCHEDULE 13D/A Jan 16, 2025
4 Jan 7, 2025 4
4 Jan 7, 2025 4
4 Jan 7, 2025 4
4 Jan 7, 2025 4
SC 13G/A Nov 7, 2024 SC 13G/A
SC 13G Nov 7, 2024 SC 13G
10-Q Nov 1, 2024 10-Q
4 Oct 15, 2024 4
3 Oct 15, 2024 3
8-K Oct 15, 2024 8-K
4 Oct 11, 2024 4
4 Oct 11, 2024 4
4 Oct 11, 2024 4
4 Oct 11, 2024 4
3 Oct 11, 2024 3
8-K Oct 7, 2024 8-K
8-K Sep 18, 2024 8-K
← Newer Page 5 of 15 · 351 filings Older →